NSE filing, NSE: THYROCARE. Summary written from the filing by ALFA Finder's alert engine.
Thyrocare Technologies Ltd: key numbers
- Share price
- ₹495.50
- Market cap
- ₹7,887 Cr
- Revenue (annual)
- ₹829.0 Cr
- Net profit (annual)
- ₹163.0 Cr
- P/E (TTM)
- 54.7×Sector 54.5×
- Promoter holding
- 51.02%-9.90% QoQ
- FII holding
- 9.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Thyrocare Technologies Ltd
All →Thyrocare Technologies Other Announcement
Thyrocare disclosed NSE market purchases by an immediate relative and a KMP on 2 November 2026. Combined consideration is about Rs 0.11 Crore, with no promoter involved.
- Value
- ₹0.11 Cr
Thyrocare Technologies Merger & Restructuring Worth ₹141.4 Cr
Thyrocare agreed to sell its entire stake in subsidiary Nueclear Healthcare to Trovera. The consideration is about Rs 141.40 Crore, including preference shares and cash.
- Value
- ₹141.4 Cr
Thyrocare Technologies Annual General Meeting
Thyrocare Technologies reported postal ballot voting results approving the purchase of land and building from, and divestment of its entire shareholding in, Nueclear Healthcare Limited.
Thyrocare Technologies Earnings Call Transcript: Key Takeaways
Thyrocare reports robust 24% growth, pivoting from volume-led routine testing to specialized diagnostics under new management. High operational leverage is evident as PAT growth significantly outpaced revenue.
- Call
- Guides 20% growth
Thyrocare Technologies Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹270.8 Cr (+25.1%), EBITDA ₹89.3 Cr (33.0% margin), PAT before exceptions ₹60.2 Cr (+25.7%). Debt-free; NHL radiology divestment pending.
Thyrocare Technologies Results Update
Thyrocare Technologies reported Q2FY27 consolidated revenue of Rs 270.8 Cr, up 25.1% YoY, with PAT before exceptions of Rs 60.2 Cr. The press release also notes a Rs 45 Cr non-cash NHL impairment tied to a proposed divestment.
Other results correction announcements
All →City Pulse Multiventures Results Correction
City Pulse Multiventures resubmitted its H1 results after fixing typos in balance-sheet figures. The changes are clerical, with no material impact.
Susan Electricals India Results Correction
Susan Electricals India Ltd resubmitted its standalone financial results and a revised auditor's report for the September 2026 quarter. The revision corrects a description regarding the reporting period.
Sumeet Industries Results Correction
Sumeet Industries files a corrected related party transactions statement for its Q1 FY27 integrated financial filing. The revision, filed under CIRP, is for information and record.
Polychem Results Correction
Polychem clarified its November 3, 2026 board outcome omitted unaudited Q2 and H1 results. Complete results were later uploaded under outcome, results and Reg 30 tabs.
Panth Infinity Results Correction
Panth Infracon corrected a clerical EPS error in its unaudited quarter and half-year results. Revised results were refiled with the corrected earnings per share figures.
One Mobikwik Systems Results Correction
MobiKwik corrected its consolidated Q2 and H1 FY27 EPS from ₹0.75 to ₹1.50 per share. The error was an incorrect PDF upload, with no financial impact.